Antiviral Drugs

What is molnupiravir?

Molnupiravir is an investigational medicine used to treat mild-to-moderate COVID-19 in adults:

• with positive results of direct SARS-CoV-2 viral testing, and;
• who are at high risk for progressing to severe COVID-19 including hospitalization or death, and for whom other COVID-19 treatment options authorized by the FDA are not
  accessible or clinically appropriate.

Product Details:

What is molnupiravir?

Molnupiravir is an investigational medicine used to treat mild-to-moderate COVID-19 in adults:

• with positive results of direct SARS-CoV-2 viral testing, and;
• who are at high risk for progressing to severe COVID-19 including hospitalization or death, and for whom other COVID-19 treatment options authorized by the FDA are not
  accessible or clinically appropriate.

Product Details:

Molnupiravir

Molnupiravir is an investigational medicine used to treat mild-to-moderate COVID-19 in adults:

• with positive results of direct SARS-CoV-2 viral testing, and;
• who are at high risk for progressing to severe COVID-19 including hospitalization or death, and for whom other COVID-19 treatment options authorized by the FDA are not
  accessible or clinically appropriate.

Product Details:

Molnupiravir

Molnupiravir is an investigational medicine used to treat mild-to-moderate COVID-19 in adults:

• with positive results of direct SARS-CoV-2 viral testing, and;
• who are at high risk for progressing to severe COVID-19 including hospitalization or death, and for whom other COVID-19 treatment options authorized by the FDA are not
  accessible or clinically appropriate.

Product Details:

Jenburkt pharmaceuticals launches Favivent for the treatment of gentle to direct instances of COVID-19 in India.